AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 100 filers reported holding AVROBIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $22,000 | -70.7% | 16,541 | -15.2% | 0.00% | – |
| Q4 2021 | $75,000 | -72.4% | 19,503 | -60.0% | 0.00% | – |
| Q3 2021 | $272,000 | -38.7% | 48,741 | -2.5% | 0.00% | -100.0% |
| Q2 2021 | $444,000 | -34.7% | 49,978 | -6.8% | 0.00% | 0.0% |
| Q1 2021 | $680,000 | +3.3% | 53,597 | +13.6% | 0.00% | 0.0% |
| Q4 2020 | $658,000 | +7.2% | 47,179 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $614,000 | -24.5% | 47,179 | +1.3% | 0.00% | 0.0% |
| Q2 2020 | $813,000 | +46.8% | 46,577 | +30.7% | 0.00% | 0.0% |
| Q1 2020 | $554,000 | -14.2% | 35,627 | +10.9% | 0.00% | 0.0% |
| Q4 2019 | $646,000 | +42.6% | 32,111 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $453,000 | +15.3% | 32,111 | +33.0% | 0.00% | 0.0% |
| Q2 2019 | $393,000 | -9.7% | 24,147 | +22.5% | 0.00% | 0.0% |
| Q1 2019 | $435,000 | +184.3% | 19,706 | +114.1% | 0.00% | – |
| Q4 2018 | $153,000 | -68.0% | 9,206 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $478,000 | – | 9,206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |